Cathie Wood: portfolio of ARK Investment Management
Cathie Wood leads ARK Investment Management, which offers actively managed funds focused on technology and innovation.
Source: 13F filing with the US Securities and Exchange Commission dated Nov 13, 2026. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included. Form 13F filingInvestment managers with discretion over at least 100 million USD in reportable US securities (mainly stocks and ETFs, plus options and convertible bonds) report their holdings to the SEC within 45 days after each quarter. Short positions, securities traded only abroad and cash are not included.Example: Positions as of 30 Sep, filed on 14 Nov → they are already six weeks old when published.More in the Academy: Glossary
- Total value of stock positions
- 17.4B USD
- Positions
- 181
- Share of the ten largest
- 40.1%
The ten largest positions Q3 2026
- Tesla, Inc. 6.9%▲ +22.2%
- Space Exploration Technologies (Class A) 5.9%▲ +50.7%
- Tempus AI 4.4%▼ −6.6%
- Twist Bioscience Corp 3.8%▼ −25.3%
- Nvidia 3.4%▲ +85.4%
- 10X Genomics Inc 3.3%▼ −37.3%
- Circle Internet Group 3.2%▲ +50.4%
- CRISPR Therapeutics AG 3.2%▲ +6.3%
- Coinbase 3.1%▲ +16.6%
- Robinhood Markets 3.0%▼ −12.1%
Show all positions of this quarter
Choose a quarter (40 filings)
- Q3 2026
- Q2 2026
- Q1 2026
- Q4 2025
- Q3 2025
- Q2 2025
- Q1 2025
- Q4 2024
- Q3 2024
- Q2 2024
- Q1 2024
- Q4 2023
- Q3 2023
- Q2 2023
- Q1 2023
- Q4 2022
- Q3 2022
- Q2 2022
- Q1 2022
- Q4 2021
- Q3 2021
- Q2 2021
- Q1 2021
- Q4 2020
- Q3 2020
- Q2 2020
- Q1 2020
- Q4 2019
- Q3 2019
- Q2 2019
- Q1 2019
- Q4 2018
- Q3 2018
- Q2 2018
- Q1 2018
- Q4 2017
- Q3 2017
- Q2 2017
- Q1 2017
- Q4 2016
All positions Q3 2026
| Symbol | Weight in previous quarter | Shares in previous quarter | Value in previous quarter | Change |
|---|---|---|---|---|
| Strata Critical Medical Inc | < 0.1% | 2,730,855 | 14.4M USD | sold out |
| HON Honeywell Technologies | < 0.1% | 23,262 | 5.2M USD | sold out |
| Teva Pharmaceutical Industries | < 0.1% | 68,653 | 2.3M USD | sold out |
| Kamada Ltd | < 0.1% | 263,304 | 1.9M USD | sold out |
| Enlivex Ltd | < 0.1% | 2,382,731 | 1.3M USD | sold out |
| Nano-X Imaging Ltd | < 0.1% | 806,614 | 935.7K USD | sold out |
| Octave Intelligence PLC | < 0.1% | 8,897 | 145.0K USD | sold out |
| ARK Genomic Revolution ETF | < 0.1% | 1,659 | 69.8K USD | sold out |
| Vanguard Growth ETF | < 0.1% | 768 | 66.2K USD | sold out |
| Dauch Corporation | < 0.1% | 6,386 | 34.6K USD | sold out |
| State Street SPDR S&P Biotech ETF | < 0.1% | 94 | 14.8K USD | sold out |
| iShares Expanded Tech-Software Sector ETF | < 0.1% | 56 | 5.1K USD | sold out |
| State Street SPDR S&P Capital Markets ETF | < 0.1% | 19 | 2.8K USD | sold out |
| State Street SPDR S&P Health Care Equipment ETF | < 0.1% | 21 | 1.8K USD | sold out |
| State Street SPDR S&P Aerospace & Defense ETF | < 0.1% | 3 | 729.0 USD | sold out |
| Fidelity MSCI Communication Services Index ETF | < 0.1% | 7 | 482.0 USD | sold out |
| iShares U.S. Broker-Dealers & Securities Exchanges ETF | < 0.1% | 2 | 424.0 USD | sold out |
Plus 1 option position, value of the underlying shares as reported 766.3K USD – not included in the weights.
The filing states the value of the shares the options refer to. Whether a put is a hedge or a bet on falling prices is not stated in the filing.
- ARK Innovation ETF Call 766.3K USD
Breakdown by sector
- Technology 18.1%
- Financials 13.1%
- Consumer Discretionary 10.0%
- Communication Services 4.2%
- Industrials 4.0%
- Health Care 2.2%
- not in our coverage 48.4%
Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.
Follow as a favorites list
With a free account you can turn the 61 stocks of this portfolio that we cover into your own favorites list.
How to read this page
- Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
- Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
- Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.
All superinvestor portfolios Screener: stocks held by superinvestors